QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nexalin-technology-receives-approval-to-sell-its-gen-2-console-device-in-israel

Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency S...

 nexalin-technology-announces-three-independent-peer-reviewed-clinical-studies-along-with-internal-data-show-that-its-15-ma-gen-2-nexalin-difs-technology-can-improve-cognition-restore-brain-activity-and-enhance-neuron-connectivity-in-patients-with-alzheimers-disease

Nexalin Technology, Inc. (NASDAQ:NXL) (the "Company" or "Nexalin"), the leader in Deep Intracranial Frequency S...

 nexalin-technology-enters-amendment-no-2-to-equity-distribution-agreement-amendment-increases-maximum-shares-offering-price-to-10m

- SEC Filing

 why-is-micro-cap-stock-nexalin-technology-rallying-on-wednesday

Nexalin stock surged as new clinical data showed its Gen-2 device improved cognition and brain connectivity in mild Alzheimer&#...

 nexalin-announces-publication-of-additional-clinical-data-in-radiology-showing-proprietary-15-ma-gen-2-nexalin-difs-technology-improves-cognitive-performance-and-enhances-brain-network-connectivity-in-ad-patients

Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Fre...

 nexalin-secures-15-yr-us-design-patent-for-halo-clarity-neuromodulation-device

Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)) (the "Company" or "Nexalin"), the leader in Deep Intracranial Fre...

 nexalin-technology-q2-2025-gaap-eps-010-up-from-017-yoy-sales-70588k-up-from-26840k-yoy

Nexalin Technology (NASDAQ:NXL) reported quarterly losses of $(0.10) per share. This is a 41.18 percent increase over losses of...

 nexalin-technology-justin-van-fleet-to-serve-as-cfo-starting-august-1-2025

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION